跳至主要内容
临床试验/ITMCTR2000003052
ITMCTR2000003052尚未招募1 期

Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19)

The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1) The confirmed patient (or legal guardian) agrees to participate in the study and signs the informed consent form;
  • 2) aged 18 to 65 years;
  • 3) The time interval between the onset of symptoms and random enrollment is within 8 days (the onset of symptoms is mainly based on the occurrence of fever);
  • 4) Real-time fluorescent RT-PCR of respiratory specimens or blood specimens to detect patients with 2019-nCoV nucleic acid positive;
  • 5) Patients were diagnosed as type 3 patients with mild, common and severe cases according to the Diagnosis and Treatment Scheme for 2019-nCoV (Trial Version 6).

排除标准

  • 1) Any situation where the solution cannot be carried out safely;
  • 2) Allergic constitution, allergic to one or more foods or drugs;
  • 3) Severe basic diseases affecting survival, including uncontrolled clinically significant heart, lung, kidney, digestive, hematological, neuropsychiatric diseases, immune diseases, metabolic diseases or malignant tumors, severe malnutrition;
  • 4) pregnant or lactating women;
  • 5) The patient may be transferred to a non-participating hospital within 72 hours;
  • 6) Those who have continued to use immunosuppressive agents or organ transplants in the past 6 months;
  • 7) Within 15 days before enrollment, during the hospitalization period, any patient who is being treated with antiviral drugs other than this program during treatment;
  • 8) People who cannot cooperate with mental state, suffer from mental illness, have no self-control, and cannot express clearly;
  • 9) History of HBV, HCV, TPPA, HIV, and pancreatitis before infection;
  • 10) Those who are participating in other clinical trials.

研究者

发起方
The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University

相似试验